Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ResMed Inc. Common Stock (NY:RMD)

247.84 -11.17 (-4.31%)
Streaming Delayed Price Updated: 3:00 PM EST, Feb 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about ResMed Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
News headline image
ResMed Among Top Stocks For Recent And Long-Term Profit Growth ↗
A Relative Strength Rating upgrade for ResMed shows improving technical performance. Will it continue? 
Via Investor's Business Daily
News headline image
Exploring the top movers within the S&P500 index during today's session. ↗
Curious about the top performers within the S&P500 index one hour before the close of the markets on Wednesday? Dive into the list of today's session's top gainers and losers for a comprehensive... 
Via Chartmill
News headline image
Beyond The Numbers: 6 Analysts Discuss ResMed Stock ↗
 
Via Benzinga
News headline image
Discover which S&P500 stocks are making waves on Wednesday. ↗
Let's have a look at what is happening on the US markets in the middle of the day on Wednesday. Below you can find the top S&P500 gainers and losers in today's session. 
Via Chartmill
News headline image
ResMed Earnings Analysis: Q2 Recap ↗
 
Via Benzinga
News headline image
Gapping S&P500 stocks in Wednesday's session ↗
Seeking insights into today's market movers? Discover the S&P500 gap up and gap down stocks in today's session on Wednesday. Stay informed about the latest market trends. 
Via Chartmill
News headline image
2 Reasons to Like RMD and 1 to Stay Skeptical
Since September 2024, ResMed has been in a holding pattern, posting a small loss of 4.8% while floating around $233.10. The stock also fell short of the S&P 500’s 6.2% gain during that period. 
Via StockStory
Topics Stocks
News headline image
Reflecting On Patient Monitoring Stocks’ Q4 Earnings: DexCom (NASDAQ:DXCM)
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how patient monitoring stocks fared in Q4, starting with DexCom... 
Via StockStory
Topics Artificial Intelligence
News headline image
Here's How Much $1000 Invested In ResMed 10 Years Ago Would Be Worth Today ↗
 
Via Benzinga
News headline image
ResMed’s Fifth Annual Global Sleep Survey Reveals a World Struggling with Poor Sleep
New insights from 30,026 people across 13 markets show the global scale of poor sleep and its impact on health, work, and relationships 
From ResMed Inc.
Via GlobeNewswire
News headline image
Earnings To Watch: Masimo (MASI) Reports Q4 Results Tomorrow
Medical tech company Masimo (NASDAQ:MASI) will be reporting earnings tomorrow after the bell. Here’s what to look for. 
Via StockStory
News headline image
Insulet Earnings: What To Look For From PODD
Insulin delivery company Insulet Corporation (NASDAQ:PODD) will be announcing earnings results tomorrow after market close. Here’s what to expect. 
Via StockStory
News headline image
iRhythm (IRTC) To Report Earnings Tomorrow: Here Is What To Expect
Medical technology company iRhythm Technologies (NASDAQ:IRTC) will be announcing earnings results tomorrow afternoon. Here’s what investors should know. 
Via StockStory
News headline image
DexCom (DXCM) To Report Earnings Tomorrow: Here Is What To Expect
Medical device company DexCom (NASDAQ:DXCM) will be reporting earnings tomorrow after the bell. Here’s what investors should know. 
Via StockStory
News headline image
ResMed Getting Close To Elite Stock Group Entry ↗
ResMed also boasts a 93 Composite Rating. The best growth stocks often have a 90 or higher Composite as they begin their biggest runs. 
Via Investor's Business Daily
News headline image
Stock Of The Day: Different Ways To Profit From SoundHound ↗
Shares of SoundHound AI are trading within a range. Some traders will get involved if the stock breaks out or breaks down. 
Via Benzinga
Topics Artificial Intelligence
News headline image
Stock Of The Day: Trading The Range In ResMed ↗
If shares of ResMed (RMD) reach support, potential buyers may start to outbid each other. This could force the shares into an uptrend. 
Via Benzinga
News headline image
What You Missed On Friday ↗
Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. 
Via Talk Markets
Topics Stocks / Equities
News headline image
What's going on in today's session: S&P500 movers ↗
Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Friday. 
Via Chartmill
News headline image
ResMed (NYSE:RMD) Posts Better-Than-Expected Sales In Q4 But Stock Drops
Medical device company ResMed (NYSE:RMD) announced better-than-expected revenue in Q4 CY2024, with sales up 10.3% year on year to $1.28 billion. Its non-GAAP profit of $2.43 per share was 5.2% above... 
Via StockStory
News headline image
In today's session, there are S&P500 stocks with remarkable trading volume. ↗
Discover the S&P500 stocks that are experiencing unusual trading volume in today's session. Find out more about these stocks below. 
Via Chartmill
News headline image
Top S&P500 movers in Friday's session ↗
Stay informed about the performance of the S&P500 index in the middle of the day on Friday. Uncover the top gainers and losers in today's session for valuable insights. 
Via Chartmill
News headline image
Tech Stocks Rally, S&P 500 Flirts With Records, Gold Extends All-Time Highs: What's Driving Markets Friday? ↗
Major stock indices have completed their recovery following Monday's sharp drop, buoyed by tech stocks rallying on the back of solid earnings and positive macroeconomic data. The S&P 500 index stands... 
Via Benzinga
Topics Stocks
News headline image
Friday's session: gap up and gap down stock in the S&P500 index ↗
Stay updated with the S&P500 gap up and gap down stocks on Friday. Get a glimpse of the market's movement during today's session. 
Via Chartmill
News headline image
ResMed: Digital Health Drives Q2 Growth ↗
ResMed reported robust earnings for the second quarter of fiscal 2025, surpassing expectations and showcasing strong growth in revenue and profitability. 
Via The Motley Fool
News headline image
ResMed, In A Buy Zone, Stays Flat After Handily Beating Earnings Views ↗
The company easily beat earnings expectations, while sales were narrowly above. 
Via Investor's Business Daily
News headline image
ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2025
From ResMed Inc.
Via GlobeNewswire
News headline image
Reasonable Growth, Debt Levels, and a High ROIC Make RESMED INC (NYSE:RMD) Appealing to Quality Investors. ↗
A fundamental analysis of (NYSE:RMD): Why Quality-Oriented Investors Should Consider NYSE:RMD. 
Via Chartmill
News headline image
Wall Street Remains Flat, Microsoft Eyes Heaviest Drop Since Late 2022, Gold Sets Fresh Records: What's Driving Markets Thursday? ↗
Wall Street is struggling to find risk-on momentum, with major indexes stuck near the flatline at midday as investors assess the latest earnings reports from mega-cap tech stocks and... 
Via Benzinga
News headline image
Earnings Scheduled For January 30, 2025 ↗
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.